Ribociclib Kisqali 200mg Tablets

  • Product Name : Ribociclib Kisqali 200mg Tablets
  • Category : Anti Cancer
  • Manufacturer Name : Novartis
  • Trade Name : Kisqali 200mg
  • Available Dosage : 200 mg
  • Packing : Box
  • Pack Insert/Leaflet :
  • Ingredients : Ribociclib
  • Formulation : Tablet
  • Therapeutic use : Metastatic breast cancer
  • Production Capacity : 100000

Description:-

Kisqali 200mg Tablet is a medication employed in the treatment of metastatic breast cancer. It functions as an anti-cancer drug by impeding the growth of cancer cells and eventually inducing their demise. This action effectively addresses symptoms associated with breast cancer, such as breast lumps, abnormal nipple discharge, or changes in breast morphology.


Administration and Dosage:

Kisqali 200mg Tablet can be taken with or without food and is typically used in combination with another medication. The duration of treatment is variable and depends on individual response and requirements. It is essential to follow the specific dosage and duration prescribed by your physician. Regular blood tests may be advised during the course of treatment to monitor its efficacy and assess potential side effects.


Indications:

The primary indication for Kisqali 200mg Tablet is in the management of metastatic breast cancer.


Benefits:

Kisqali 200mg Tablet provides several benefits in the treatment of metastatic breast cancer. It can be utilized alone or in combination with other medications or therapeutic modalities such as chemotherapy. This medication is typically employed when other treatments have failed to yield significant improvement, and the cancer has metastasized to other sites. Kisqali 200mg Tablet effectively alleviates symptoms associated with breast cancer, including breast lumps, abnormal nipple discharge, or changes in breast appearance. Furthermore, it inhibits or arrests the growth of cancer cells and prevents their proliferation. If any side effects occur, it is advisable to discuss them with your healthcare provider.


Mechanism of Action:

Kisqali 200mg Tablet functions as an anti-cancer agent by inhibiting proteins known as kinases, which play a crucial role in the growth and division of cells. By blocking these proteins, the medication slows down the growth of cancer cells, ultimately leading to their destruction.